Division of Behavioral Sciences and Community Health, University of Connecticut School of Dental Medicine, Farmington, CT 06030, USA.
Int J Oral Maxillofac Surg. 2012 Dec;41(12):1558-62. doi: 10.1016/j.ijom.2012.04.019. Epub 2012 May 31.
Quality of life outcomes among patients receiving implants have been well studied, but little is known about the effects of bone augmentation in this therapy. The purpose of this paper was to assess quality of life changes among postmenopausal women receiving dental implants with bone augmentation during implant therapy. This was a prospective cohort study. 48 patients were recruited at the University of Connecticut Health Center and received one of three surgical augmentation methods: dehiscence repair; expansion alone; or expansion with dehiscence repair. The predictor variable was type of augmentation procedure. Quality of life measured by the Oral Health Impact Profile-14 (OHIP-14) was the outcome measure and was assessed prior to treatment, 1 week, 8 weeks and 9 months after surgery. Changes in OHIP-14 were evaluated by repeated measures analysis of variance. The mean initial OHIP-14 scores on total items checked were 4.6 (SD=3.0) and declined significantly to 2.0 (SD=2.0) at 9 months. The mean baseline severity score was 15.4 (SD=8.9) improving significantly to 7.5 (SD=7.6) at 9 months. Type of augmentation procedure did not affect quality of life. The participants' quality of life improved continuously from the pretreatment to the 9-month assessment, including improvements 1 week after implant placement.
接受种植体治疗的患者的生活质量已得到充分研究,但对于该治疗中骨增量的影响知之甚少。本文旨在评估接受骨增量种植体治疗的绝经后妇女的生活质量变化。这是一项前瞻性队列研究。在康涅狄格大学健康中心招募了 48 名患者,并接受了三种手术增强方法之一:裂隙修复;单独扩张;或裂隙修复与扩张。预测变量是增强程序的类型。通过 14 项口腔健康影响量表(OHIP-14)评估生活质量,在治疗前、治疗后 1 周、8 周和 9 个月进行评估。通过重复测量方差分析评估 OHIP-14 的变化。总检查项目的初始 OHIP-14 平均得分为 4.6(SD=3.0),9 个月后显著下降至 2.0(SD=2.0)。基线严重程度平均得分为 15.4(SD=8.9),9 个月后显著改善至 7.5(SD=7.6)。增强程序的类型并不影响生活质量。参与者的生活质量从治疗前到 9 个月的评估持续改善,包括种植体放置后 1 周的改善。